Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2005; 11(43): 6843-6847
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6843
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6843
Table 3 Tissue TNF-α levels in treated and untreated groups of animals (mean±SD)
| Group | Tissue TNF-α (pg/mL) | P value |
| 1 (Infliximab 5) | 0.47±0.44 | <0.0001 |
| 2 (Infliximab 10) | 1.09±0.86 | <0.0001 |
| 3 (Infliximab 15) | 0.43±0.31 | <0.0001 |
| 4 (Untreated) | 18.73±10.53 | |
| 5 (Healthy animals) | 0.00+/–0.0 |
- Citation: Triantafillidis JK, Papalois AE, Parasi A, Anagnostakis E, Burnazos S, Gikas A, Merikas EG, Douzinas E, Karagianni M, Sotiriou H. Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 2005; 11(43): 6843-6847
- URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6843.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i43.6843